$COR·8-K

Cencora, Inc. · May 29, 5:10 PM ET

Compare

Cencora, Inc. 8-K

Research Summary

AI-generated summary

Updated

Cencora Appoints New CFO, Reaffirms FY2026 Guidance

What Happened

  • Cencora announced on May 27, 2026 that Eva C. Boratto will become Executive Vice President and Chief Financial Officer, effective June 29, 2026. She succeeds James F. Cleary, who is retiring from the CFO role and will remain in an advisory capacity through the end of 2026. The company entered into an employment agreement with Ms. Boratto on May 23, 2026.
  • The company also issued a press release reaffirming its fiscal 2026 adjusted diluted EPS guidance of $17.70 to $17.90 and reaffirmed its long‑term targets of 7%–10% adjusted operating income growth and 10%–14% adjusted diluted EPS growth.

Key Details

  • New CFO: Eva C. Boratto, age 59; most recently CFO of Bath & Body Works (since Aug 2023); prior finance leadership roles at Opentrons Labwork, CVS Health (multiple CFO and finance roles), and 20 years at Merck. She serves on the boards of Mars, Inc. and UPS.
  • Compensation: annual base salary of $1,000,000 and an annual bonus target of 100% of base salary; eligible for the same short‑ and long‑term incentive arrangements as other Cencora executives.
  • Employment terms: agreement (effective June 29, 2026) includes standard termination and severance provisions and non‑competition/confidentiality obligations for named executive officers.
  • Transition: James F. Cleary will retire from the CFO role but remain as an advisor through 2026.

Why It Matters

  • Leadership change at the CFO level is material for investors because the CFO guides financial reporting, forecasting and capital allocation. Ms. Boratto brings extensive retail and healthcare finance experience and board audit committee experience.
  • Reaffirmation of FY2026 adjusted EPS and long‑term growth targets removes near‑term guidance uncertainty and signals management’s confidence in reaching its financial goals for the year.
  • Compensation and contractual terms are disclosed, which can affect future cash flow and potential severance or change‑in‑control costs; the filing also includes related employment and sign‑on arrangements.

Loading document...